UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Genpact Limited (NYSE:G - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 111,318 shares of the business services provider's stock, valued at approximately $4,365,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.06% of Genpact as of its most recent filing with the SEC.
Several other institutional investors have also recently added to or reduced their stakes in the business. Jensen Investment Management Inc. lifted its position in Genpact by 6.4% in the third quarter. Jensen Investment Management Inc. now owns 189,985 shares of the business services provider's stock valued at $7,449,000 after acquiring an additional 11,410 shares during the last quarter. Vanguard Personalized Indexing Management LLC boosted its position in shares of Genpact by 53.1% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 49,134 shares of the business services provider's stock valued at $1,580,000 after purchasing an additional 17,034 shares during the period. Nisa Investment Advisors LLC grew its stake in Genpact by 329.6% during the 2nd quarter. Nisa Investment Advisors LLC now owns 10,525 shares of the business services provider's stock worth $339,000 after buying an additional 8,075 shares during the last quarter. Access Investment Management LLC increased its position in Genpact by 44.0% during the third quarter. Access Investment Management LLC now owns 212,875 shares of the business services provider's stock worth $8,347,000 after buying an additional 65,070 shares during the period. Finally, Retirement Systems of Alabama increased its position in Genpact by 1.7% during the second quarter. Retirement Systems of Alabama now owns 449,845 shares of the business services provider's stock worth $14,481,000 after buying an additional 7,645 shares during the period. Hedge funds and other institutional investors own 96.03% of the company's stock.
Analysts Set New Price Targets
G has been the topic of several recent research reports. TD Cowen boosted their price target on Genpact from $40.00 to $45.00 and gave the company a "hold" rating in a research report on Friday, November 8th. Jefferies Financial Group lifted their price objective on shares of Genpact from $35.00 to $40.00 and gave the company a "hold" rating in a research report on Monday, September 9th. Needham & Company LLC boosted their price objective on shares of Genpact from $42.00 to $55.00 and gave the company a "buy" rating in a research note on Monday, November 11th. JPMorgan Chase & Co. raised their target price on shares of Genpact from $35.00 to $43.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Finally, Robert W. Baird boosted their price target on shares of Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research note on Friday, November 8th. Eight analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $42.33.
Read Our Latest Research Report on Genpact
Insider Activity
In related news, CEO Balkrishan Kalra sold 9,000 shares of the company's stock in a transaction on Monday, November 25th. The shares were sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the sale, the chief executive officer now directly owns 267,404 shares of the company's stock, valued at approximately $12,407,545.60. This represents a 3.26 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.80% of the company's stock.
Genpact Trading Down 0.1 %
G traded down $0.06 during midday trading on Friday, hitting $44.67. The company's stock had a trading volume of 913,785 shares, compared to its average volume of 1,348,975. Genpact Limited has a 52-week low of $30.23 and a 52-week high of $47.98. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The firm has a 50-day moving average price of $42.28 and a two-hundred day moving average price of $37.67. The firm has a market cap of $7.88 billion, a P/E ratio of 12.29, a PEG ratio of 1.56 and a beta of 1.18.
Genpact Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 23rd. Stockholders of record on Monday, December 9th will be issued a $0.1525 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.37%. Genpact's dividend payout ratio (DPR) is 16.76%.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles
![Institutional Ownership by Quarter for Genpact (NYSE:G)](https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&Symbol=G)
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.